Ipsen Press Releases | Latest News & Updates_emc易倍官网入口

Topics

Period

Filter by

Reset

Showing: 1 – 5 of 256 Press Releases

Show

Sort

30 July 2026

30 July 2026

Download Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

H1 2026 – Results Announcement (707.30 KB)

H1 2026 – Results Highlights (191.92 KB)

H1 2026 – Investor Presentation (1.93 MB)

H1 2026 – Results Webcast Replay

29 July 2026

29 July 2026

Download Ipsen nominates Catherine Bradley to its Board of Directors as independent Director

Ipsen nominates Catherine Bradley to its Board of Directors as independent Director

24 July 2026

24 July 2026

Download Ipsen provides update on Phase III BOLD trial in biliary atresia

Ipsen provides update on Phase III BOLD trial in biliary atresia

22 July 2026

22 July 2026

Download Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

13 July 2026

13 July 2026

Download IQIRVO? demonstrates statistically significant improvement in ALP normalization in patients with PBC in Phase IIIb ELSPIRE study

IQIRVO? demonstrates statistically significant improvement in ALP normalization in patients with PBC in Phase IIIb ELSPIRE study

Your dedicated contacts

Sally Bain

Head of Global Media Relations

+1 857 320 0517

emc易倍官网入口sally.bain@ipsen.com

Anne Liontas

France Media Relations

emc易倍官网入口+33 7 67 34 72 96

emc易倍官网入口anne.liontas.ext@ipsen.com

Stay updated

Register to receive our latest news

2026-08-02 9:20:56